Company Analysis Medifast, Inc.
1. Summary
Advantages
- Price (13.86 $) is less than fair price (27.45 $)
- The company's current efficiency (ROE=49.34%) is higher than the sector average (ROE=11.92%)
Disadvantages
- Dividends (0%) are below the sector average (1.36%).
- The stock's return over the last year (-62.61%) is lower than the sector average (-10.9%).
- Current debt level 7.1% has increased over 5 years from 6.99%.
Similar companies
2. Share price and performance
2.1. Share price
2.2. News
2.3. Market efficiency
| Medifast, Inc. | Consumer Discretionary | Index | |
|---|---|---|---|
| 7 days | -2% | -2.8% | -1.2% |
| 90 days | -18.3% | -16.2% | -6.6% |
| 1 year | -62.6% | -10.9% | 6.9% |
MED vs Sector: Medifast, Inc. has significantly underperformed the "Consumer Discretionary" sector by -51.71% over the past year.
MED vs Market: Medifast, Inc. has significantly underperformed the market by -69.52% over the past year.
Stable price: MED is not significantly more volatile than the rest of the market on "New York Stock Exchange" over the last 3 months, with typical variations of +/- 5% per week.
Long period: MED with weekly volatility of -1.2% over the past year.
3. Summary of the report
4. Fundamental Analysis
4.1. Stock price and price forecast
Below fair price: The current price (13.86 $) is lower than the fair price (27.45 $).
Price significantly below the fair price: The current price (13.86 $) is 98.1% lower than the fair price.
4.2. P/E
P/E vs Sector: The company's P/E (7.32) is lower than that of the sector as a whole (34.01).
P/E vs Market: The company's P/E (7.32) is lower than that of the market as a whole (73.03).
4.2.1 P/E Similar companies
4.3. P/BV
P/BV vs Sector: The company's P/BV (3.61) is lower than that of the sector as a whole (3.86).
P/BV vs Market: The company's P/BV (3.61) is lower than that of the market as a whole (22.33).
4.3.1 P/BV Similar companies
4.4. P/S
P/S vs Sector: The company's P/S indicator (0.6791) is lower than that of the sector as a whole (3).
P/S vs Market: The company's P/S indicator (0.6791) is lower than that of the market as a whole (16).
4.4.1 P/S Similar companies
4.5. EV/Ebitda
EV/Ebitda vs Sector: The company's EV/Ebitda (4.7) is lower than that of the sector as a whole (49.25).
EV/Ebitda vs Market: The company's EV/Ebitda (4.7) is lower than that of the market as a whole (23.03).
5. Profitability
5.1. Profitability and revenue
5.2. Earnings per share - EPS
5.3. Past profitability Net Income
Yield Trend: Negative and has fallen by -0.6774% over the last 5 years.
Accelerating profitability: The return for the last year (0%) exceeds the average return for 5 years (-0.6774%).
Profitability vs Sector: The return for the last year (0%) exceeds the return for the sector (-47.7%).
5.4. ROE
ROE vs Sector: The company's ROE (49.34%) is higher than that of the sector as a whole (11.92%).
ROE vs Market: The company's ROE (49.34%) is higher than that of the market as a whole (25.16%).
5.5. ROA
ROA vs Sector: The company's ROA (32.08%) is higher than that of the sector as a whole (7.83%).
ROA vs Market: The company's ROA (32.08%) is higher than that of the market as a whole (6.67%).
5.6. ROIC
ROIC vs Sector: The company's ROIC (76.24%) is higher than that of the sector as a whole (8.22%).
ROIC vs Market: The company's ROIC (76.24%) is higher than that of the market as a whole (9.31%).
7. Dividends
7.1. Dividend yield vs Market
Low yield: The dividend yield of the company 0% is below the average for the sector '1.36%.
7.2. Stability and increase in payments
Dividend stability: The company's dividend yield 0% has been steadily paid over the past 7 years, DSI=0.79.
Weak dividend growth: The company's dividend yield 0% has been growing weakly or stagnant over the past 5 years. Growth over only 0 years.
7.3. Payout percentage
Dividend Coverage: Current payments from income (73.45%) are at a comfortable level.
Pay for your subscription
More functionality and data for company and portfolio analysis is available by subscription
